Delivering HEOR Impact Through Global Member Engagement
ISPOR chapters operate throughout the world to develop the field and advance HEOR excellence in their regions. More than 85 ISPOR chapters work globally to help advance the Society's mission. Additionally, well over half of ISPOR’s regional chapters are based in low- and middle-income countries, extending the impact of HEOR in regions where healthcare systems are developing capacity.
Case Illustrations
Chapter Members Contributing to Development of National Guidelines
Summary...
What Was Done?
ISPOR regional chapter members were involved in the development of national HEOR guidelines in Algeria, Chile, Czech Republic, Ghana, India, Hungary, South Africa, New Zealand, and Thailand.
What Was the Impact?
Health technology assessment (HTA), pricing, and reimbursement or economic evaluations are being influenced in numerous countries around the world through engagement of ISPOR chapters with national governments.
Contributing to Guidelines Development in China
Summary...
What Was Done?
ISPOR chapter members in China participated in Pharmacoeconomic/Health Technology Assessment (PE/HTA) appraisal for the national health insurance negotiation with manufacturers.
What Was the Impact?
HEOR expertise of members was included in key national health insurance processes.
Local Pharmacoeconomic Guidelines Published in Slovakia
Summary...
What Was Done?
The ISPOR Slovakia Chapter published new Pharmacoeconomic (PE) Guidelines in 2022. This new edition of PE Guidelines is supplemented by new knowledge and sources of information, notably ISPOR Good Practices Report, “Consolidated Health Economic Evaluation Reporting Standards, CHEERS 2022.”
What Was the Impact?
The updated PE Guidelines will help assure that the most recent HEOR information and guidance is available for use in Slovakia.
Contributing to an Economic Working Group in Thailand
Summary...
What Was Done?
In Thailand, ISPOR chapter members were included in an economic working group to support the selection of National List of Essential Medicines of Thailand.
What Was the Impact?
ISPOR members contributed expertise to important guidance on essential medicines.
Supporting Universal Healthcare Discussions in the Philippines
Summary...
What Was Done?
Since the establishment of Universal Health Coverage (UHC) in the Philippines in 2019, the ISPOR Philippines Chapter has played an important role in convening discussions with government and other healthcare stakeholders.
What Was the Impact?
Members are helping to ensure that UHC legislation in the Philippines is moving towards evidence-based implementation that adheres to principles of HEOR and patient centeredness.
Leading Pharmacoeconomic Guidelines Development in China
Summary...
What Was Done?
Members of ISPOR Beijing Chapter led the development of China’s 2020 national Pharmacoeconomic (PE) Guidelines.
What Was the Impact?
ISPOR members provided an important foundation for strengthening the quality and usability of HEOR research and methods in the region.
Contribute Your HEOR Story of Impact
Share your story of impact with ISPOR. The Society will be sharing some of the case examples submitted to highlight the profound impact that HEOR can have on informing and improving healthcare decisions.
